Matches in Wikidata for { <http://www.wikidata.org/entity/Q66406096> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q66406096 description "clinical trial" @default.
- Q66406096 description "ensayu clínicu" @default.
- Q66406096 description "klinisch onderzoek" @default.
- Q66406096 description "клінічне випробування" @default.
- Q66406096 name "OTX-15:003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract Surgery" @default.
- Q66406096 name "OTX-15:003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract Surgery" @default.
- Q66406096 type Item @default.
- Q66406096 label "OTX-15:003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract Surgery" @default.
- Q66406096 label "OTX-15:003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract Surgery" @default.
- Q66406096 prefLabel "OTX-15:003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract Surgery" @default.
- Q66406096 prefLabel "OTX-15:003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract Surgery" @default.
- Q66406096 P1050 Q66406096-ADA5C02C-96D7-4AA3-804B-75CCAF410398 @default.
- Q66406096 P1050 Q66406096-BCF2A6E9-F185-4ACF-A0C2-9835E20AB29B @default.
- Q66406096 P1050 Q66406096-EF61649B-6486-4C21-A078-FA641A7555BF @default.
- Q66406096 P1132 Q66406096-737BAC18-7D7E-4BDB-8C38-0765D91AE7D3 @default.
- Q66406096 P1476 Q66406096-5D1906E2-B353-47B1-B07E-B6C2B1587049 @default.
- Q66406096 P2899 Q66406096-506D5496-C676-40AE-8C0A-388D841B789E @default.
- Q66406096 P3098 Q66406096-4DA28784-B516-4021-BF27-8F4E779B7E6D @default.
- Q66406096 P31 Q66406096-FDCD140A-FFE4-4712-9FDA-E17FACF58BA2 @default.
- Q66406096 P4844 Q66406096-33E192F9-A71A-4596-B719-AFA35CCA7E64 @default.
- Q66406096 P580 Q66406096-F78DDADE-9E75-4E1B-991E-C362DE71F0F2 @default.
- Q66406096 P582 Q66406096-8B27AC3A-79DD-4C02-A2B2-B3148BCE9A2D @default.
- Q66406096 P6099 Q66406096-71FA40E7-A59C-4A51-AFB2-B3109BE1FDAD @default.
- Q66406096 P8363 Q66406096-9682DFBB-76B9-49FC-8B4E-C7284357775C @default.
- Q66406096 P1050 Q101991 @default.
- Q66406096 P1050 Q127724 @default.
- Q66406096 P1050 Q54971415 @default.
- Q66406096 P1132 "+438" @default.
- Q66406096 P1476 "A Prospective, Multicenter, Randomized, Parallel-Arm, Double-Masked, Vehicle Controlled Phase 3C Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract Surgery" @default.
- Q66406096 P2899 "+18" @default.
- Q66406096 P3098 "NCT02736175" @default.
- Q66406096 P31 Q30612 @default.
- Q66406096 P4844 Q408524 @default.
- Q66406096 P580 "2015-10-01T00:00:00Z" @default.
- Q66406096 P582 "2016-05-01T00:00:00Z" @default.
- Q66406096 P6099 Q42824827 @default.
- Q66406096 P8363 Q78089383 @default.